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Edited by Laszlo NagyAbstract ATF4 is an essential regulator in osteogenesis as well
as in stress responses to the endoplasmic reticulum (ER). We
addressed a question: Does ER stress to osteoblasts upregulate
ATF4 expression? If so, do they exhibit ATF4-mediated bone
remodeling or apoptosis? ER stress, induced by Thapsigargin
and tunicamycin, elevated a phosphorylated form of eIF2a and
ATF4, but the cellular fate depended on treatment duration.
The treatment for 1 h, for instance, activated Runx2, and type
I collagen, while the treatment for 24 h induced apoptosis. Our
observations suggest that there is a threshold for ER stress and
osteoblasts present a bi-phasic pattern of their fate.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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remodeling1. Introduction
Diﬀerentiation of osteoblasts results from a complex molec-
ular interplay involving the action of various transcription fac-
tors such as Runx2, Osterix, and ATF4. In osteoblasts, whose
primary role in bone formation is building a calcium enriched
ECM, expression of ATF4 is coordinately regulated during the
course of their diﬀerentiation [1]. It has been shown that a mu-
tant mouse lacking the ATF4 gene is unable to form any part
of a mature cytoskeleton [1].
ER stress is induced in many eukaryotic cells by a multitude
of causes including protein misfolding, UV, viral infection, and
nutritional deprivation [2]. It leads to preferential translational
expression by a mechanism involving phosphorylation of
eukaryotic translation initiation factor-2a (eIF2a) [3]. The
phosphorylated eIF2a acts – in turn – to activate the transla-
tion of ATF4. When ER stress is excessive, activation of
ATF4 expression results in apoptosis. An intriguing question
is the fate of osteoblasts that utilize ATF4 as a critical tran-
scription factor during osteogenesis.
ATF4 is known to stimulate ATF3 as well as osteoblast spe-
ciﬁc genes, while it can elevate expression of CHOP and facil-
itates to apoptosis [4]. CHOP is necessary for bone*Corresponding author. Fax: +1 317 278 9568.
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doi:10.1016/j.febslet.2007.03.063development and its anabolic eﬀects have been reported to
occur in response to bone morphogenetic protein [5,6],
although overexpression of CHOP resulted in impaired bone
formation. A speciﬁc question addressed herein is whether
ER stress would stimulate ATF4 expression in osteoblasts,
and if so, whether upregulation of ATF4 would result in
ATF4/CHOP-mediated apoptosis or activation of ATF4-
dependent bone remodeling. We hypothesized that the fate
of osteoblasts would be bi-phasic depending on stress intensity
analogous to mechanical stimulation, where excessive forces
negatively inﬂuence anabolic responses but appropriate stimu-
lations can enhance bone formation [7]. In the present studies,
we used Thapsigargin and tunicamycin as an inducer of ER
stress.2. Materials and methods
2.1. Cell culture
MC3T3 osteoblast-like cells and their C4 clone [8] were cultured in
aMEM containing 10% FBS and antibiotics. We used these two
lines, since the former was reported less sensitive to an osteogenic
agent than the latter [9]. In our PCR assay the C4 clone presented
1240-fold (N = 4) higher expression of Osteocalcin mRNA. Note that
MC3T3 cells and the C4 clone were used in the experiments for Figs.
1–3 and Figs. 4–6, respectively. Approximately 4 · 105 cells were
treated in a plastic dish with Thapsigargin (Santa Cruz Biotech.)
or tunicamycin (MP Biomedicals) at varying concentrations. The
treatment duration was continuous for up to 24 h (T24h), or in the
beginning for 5 min to 3 h.
2.2. Real-time PCR
Total RNA was extracted using an RNeasy plus mini kit (Qiagen).
Reverse transcription was conducted, and real-time PCR was per-
formed using ABI 7500 with SYBR green PCR kits (Applied Biosys-
tems). The mRNA level of the genes listed Table 1 was determined.
GAPDH was used for internal control, and the results were interpreted
using a DCT method.
2.3. Immunoblots
Cells were lysed in a RIPA lysis buﬀer containing inhibitors for
proteases and phosphatases. Isolated proteins were fractionated
using 10–15% SDS gels and electro-transferred to Immobilon-P
membranes (Millipore). Anti-rabbit IgG conjugated with HRP,
and anti caspase-3 antibodies (Cell Signaling Tech.), and antibodies
against ATF4, ATF3, and CHOP (Santa Cruz Biotech.) were used.
Anti eIF2a (pS52), anti mouse IgG conjugated with HRP, and anti
b-actin were obtained from Biosource, Amersham, and Sigma,
respectively.
2.4. Assay for cellular proliferation and cell death
Cells were treated with Thapsigargin or tunicamycin for 24 h. The
ratio of cell numbers was deﬁned as the number of harvested cellsblished by Elsevier B.V. All rights reserved.
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Fig. 1. Protein expression of ATF4 and eIF2a-p in response to Thapsigargin in MC3T3 cells. (A) Responses at 0.01–100 nM for 1 and 3 h. (B)
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blue, and the number of live and dead cells was counted using a hema-
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Fig. 2. Apoptotic cell death for continuous Thapsigargin treatments in
MC3T3 cells. (A) Cellular images. Black bar = 100 lm. (B) Ratio of
cell numbers 24 h after a continuous treatment. (C) Ratio of the
number of dead cells with respect to the total number of cells. (D)
CHOP, pro-caspase 3, and cleaved caspase 3 proteins in response to
10 nM Thapsigargin.3. Results
3.1. Induction of eIF2a-p and ATF4 proteins by Thapsigargin in
MC3T3 cells
A series of Thapsigargin concentrations were employed to
evaluate expression of eIF2a-p and ATF4 proteins. At lower
dosages of 0.01 and 0.1 nM, no detectable upregulation was
observed (Fig. 1A). At 10 and 100 nM, however, their levels
were elevated after 1 h and 3 h (Fig. 1A). At 100 nM and the
higher concentrations, they were further increased at 1 h and
3 h (Fig. 1B). Using the lowest (10 nM) and the highest
(1.5 lM) concentrations that enhanced the level of eIF2a-p
and ATF4, the 24-h expression proﬁle was determined. The
level of eIF2a-p was increased at 1, 3, 5, and 10 h, and
ATF4 elevated at 3, 5, and 10 h (Fig. 1C).
3.2. Cell death and apoptosis by Thapsigargin in MC3T3 cells
After 24-h treatment some cells appeared to be dead, and the
number of cells was reduced by 25.3 ± 4.0% in response to
10 nM Thapsigargin (Fig. 2A and B). In addition, the number
of dead cells with respect to the total number of cells was in-
creased with Thapsigargin: 2.5 ± 0.5% (control), and 20.1 ±
1.6% (10 nM) (Fig. 2C).
To examine induction of apoptosis, we determined the pro-
tein levels of CHOP, pro-caspase 3 (inactive), and cleaved cas-
pase 3 (active) (Fig. 2D). The level of CHOP started to increase
after 3 h and it became higher for a longer incubation. Pro-cas-
pase 3 level was not signiﬁcantly altered, but the level of an ac-
tive form was increased after 24 h.
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in MC3T3 cells
To examine the eﬀect of shorter exposure to Thapsigargin,
cells were incubated at 10 nM for 5 min (T5m), 15 min
(T15m), 30 min (T30m), and 1 h (T1h). All treatments raised
the level of eIF2a-p, while ATF4 was elevated only in T30m
and T1h (Fig. 3A). In response to T1 h, the mRNA level of
ATF4, Runx2, Osterix, and type I collagen was elevated 1, 3,
5, or 10 h after the onset of the treatment while the level of
osteocalcin mRNA was unchanged (Fig. 3B).3.4. Transcriptional activation with short exposure to
Thapsigargin in C4 cells
Unlike MC3T3 cells, the C4 clone has a strong osteogenic
potential and therefore a possibility of pursuing a diﬀerent
cellular fate. We therefore re-examined the eﬀects of Thapsi-
gargin on transcriptional activation using the C4 clone
(Fig. 4). In response to T1 h at 10 nM, no signiﬁcant diﬀerence
in the cell number or mortality was observed between the
control cells and the treated cells (data not shown). Out of
four transcription factors in Table 1, the level of ATF4
mRNA was elevated 2–4-fold throughout the treatments.
ATF3 mRNA was upregulated 100–1000 times. An increase
in Runx2 mRNA started at 3 h and peaked at 5 h, while
Osterix mRNA was enhanced at 1 h. The mRNA level of
CHOP was raised 10–35-fold, and Rankl mRNA was signif-
icantly up 3 h for T2h and 10 h for T3h. The mRNA level of
type 1 collagen was elevated 5 h and 10 h for T1 h. In spite of
upregulation of ATF4 and Runx2 mRNA, the level of Oste-
ocalcin mRNA was decreased down to 20–60% of the control
level.3.5. Western analysis in response to 10 nM Thapsigargin in C4
cells
Like MC3T3 cells, C4 cells showed upregulation of eIF2a-p
and ATF4 in response to T1h (Fig. 5A). Note that MC3T3
cells and their C4 clone cells exhibited two bands and a single
band for eIF2a-p, respectively. The protein level of ATF3 and
CHOP was transiently elevated for T1h treatment and dimin-
ished at 24 h. When the treatment was continuous (T24 h), the
level of ATF3 and CHOP was sustained elevated (Fig. 5A).
The temporal alteration of ATF4 mRNA and protein levels
supports translational regulation, showing that the increase
in the protein level was signiﬁcantly higher than that in the
mRNA level (Fig. 5B).3.6. Response to tunicamycin in C4 cells
Thapsigargin is an inhibitor of Ca2+ ATPase, while tunica-
mycin induces ER stress by inhibiting protein glycosylation.
The Western analysis revealed that the protein level of
eIF2a-p and ATF4 was elevated by 1 lg/ml tunicamycin
(Fig. 6A). Induction of eIF2a-p took place 3 h after the treat-
ment with tunicamycin, while it happened 1 h with Thapsigar-
gin. The treatment with 1 lg/ml tunicamycin for short time
(T1 h, and T3h) did not stimulate cell death, but the continuous
treatment (T24h) activated caspase 3 and increased cell death
(Fig. 6B). The mRNA expression of ATF4, ATF3, CHOP,
and Osteocalcin was altered similarly to the response to
Thapsigargin (Fig. 6C). However, the increase in Runx2 and
type I collagen was smaller and limited to 5 h after the treat-
ment. The mRNA level of Osterix, which was elevated approxi-
mately 2-fold with Thapsigargin, was not upregulated with
tunicamycin.
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The present study demonstrates that ER stress by Thapsi-
gargin and tunicamycin leads to two distinctive pathways –apoptosis and regulation of osteoblastogenesis. This bi-phasic
response was dependent on exposure time to ER stress: 1 h
treatment favored the pathway toward transcriptional activa-
tion of the selected genes such as Runx2 and type I collagen
as opposed to 24 h for the apoptotic pathway. Regulation of
ATF4 appeared to be involved at both transcriptional and
translational levels. Induction of ATF3 mRNA and CHOP
mRNA was observed in all treatments. These results indicate
a molecular mechanism that is sensitive to intensity of ER
stress and diﬀerentially regulates a pathway of osteoblasts.
The unique feature of ER stress to osteoblasts, revealed in
this study, was induction of genes involved in bone remodel-
ing. Unlike a continuous exposure of ER stress leading to
apoptosis, a short exposure to Thapsigargin enhanced not only
ATF4 but also an mRNA level of Rankl and transcriptional
regulators such as Runx2 and Osterix. Rankl is a critical cyto-
kine required for bone resorption through activation of osteo-
clasts. Our results are consistent with a previous report
showing that Rankl expression is elevated through the binding
of ATF4 to its regulatory DNA sequences [10]. Runx2 dictates
osteoblastogenesis through interactions with numerous regula-
tory proteins including Osterix, which is essential for calciﬁca-
tion and bone formation. It is reported that the ATF3 mRNA
level was upregulated during chondrocyte diﬀerentiation and
ATF3 overexpression activated a Runx2-dependent promoter
[11]. Therefore, the observed upregulation of Runx2 and
Osterix might be linked to elevation of ATF3.
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while tunicamycin is an inhibitor of protein glycosylation
[12]. Induction of apoptosis by the two agents has been re-
ported in various cells, and the results here are consistent with
the ATF4/CHOP medicated apoptosis [4,13]. Regarding tran-
scriptional activation for bone remodeling, our results on
mRNA expression of Osterix and type I collagen indicate that
Thapsigargin is a more potent activator than tunicamycin.
Despite the observed upregulation of ATF4 and Runx2,
Osteocalcin transcription was not activated in either cell line
by Thapsigargin or tunicamycin. The promoter of the mouse
Osteocalcin gene contains two binding motifs (OSE1, and
OSE2), and its transcription is activated through synergistic
binding of ATF4 and Runx2 to them [14]. ATF3 is a negative
regulator that shares the consensus binding motif with a familyof ATF factors [15], and therefore elevation of ATF3 might
abolish the stimulatory role of ATF4. Although the level of
Osteocalcin mRNA was decreased from 1 h in the C4 clone,
its further downregulation from 3 h is consistent with an
expression pattern of ATF3.
Phosphorylation of eIF2a is an important in skeletal devel-
opment, since a mutation in the ER kinase responsible for its
phosphorylation is shown to cause Wolcott–Rallison syn-
drome that exhibit skeletal dysplasias [16]. In summary, this
study demonstrates that ER stress driven by Thapsigargin
and tunicamycin leads to ATF4/CHOP mediated apoptosis
or stimulation of the critical genes involved in bone develop-
ment. Understanding the bi-phasic molecular mechanism
would contribute to future disease treatments and therapies
for the promotion of bone health.
Table 1
Real-time PCR primers
Gene Forward primer Backward primer
ATF3 5 0-CGAAGACTGGAGCAAAATGATG-30 5 0-CAGGTTAGCAAAATCCTCAAATAC-3 0
ATF4 5 0-TGGCGAGTGTAAGGAGCTAGAAA-3 0 5 0-TCTTCCCCCTTGCCTTACG-30
CHOP 5 0-CCACCACACCTGAAAGCAGAA-30 5 0-GGTGCCCCCAATTTCATCT-30
Col I 5 0-AAACTCCCTCCACCCCAATCT-30 5 0-TTTGGGTTGTTCGTCTGTTTCC-30
Osteocalcin 5 0-CCGGGAGCAGTGTGAGCTTA-3 0 5 0-AGGCGGTCTTCAAGCCATACT-3 0
Osterix 5 0-CCCTTCTCAAGCACCAATGG-3 0 5 0-AGGGTGGGTAGTCATTTGCATAG-30
RANKL 5 0-CCGAGACTACGGCAAGTACC-3 0 5 0-GCGCTCGAAAGTACAGGAAC-30
Runx2 5 0-AAATGCCTCCGCTGTTATGAA-30 5 0-GCTCCGGCCCACAAATCT-3 0
GAPDH 5 0-TGCACCACCAACTGCTTAG-30 5 0-GGATGCAGGGATGATGTTC-30
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